Brent Moen was named Chief Financial Officer of Anteris Technologies Global Corp., effective September 11, 2026. As of November 6, 2026, Anteris Technologies Global Corp. has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 13, 2026 to September 17, 2026, naming 3 appointments (Form 8-K, September 8, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Anteris Technologies Global Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-09-17
- · In / out: In · Person: Brent Moen · Role: Chief Financial Officer · Effective: 2026-09-11 · 8-K, 2026-09-08
- · In / out: In · Person: Susan Knight · 8-K, 2026-05-13
Anteris Technologies Global Corp. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-13 to 2026-09-17. They name 3 people. Every row below is cited to the filing it comes from, and this page adds each new change as Anteris Technologies Global Corp. files it.
Also on the record for Anteris Technologies Global Corp.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 8.7% of the class | 5%+ stakes | Source |
| September 3, 2026 | Stake report, Schedule 13G/A, by L1 Capital Pty Ltd | 11.64% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Nantahala Capital Management, LLC | 4.08% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G/A, by L1 Capital Pty Ltd | 13.46% of the class | 5%+ stakes | Source |
| August 6, 2026 | Stake report, Schedule 13G, by FMR LLC | 7.5% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Nantahala Capital Management, LLC | 6.28% of the class | 5%+ stakes | Source |
| May 4, 2026 | Stake report, Schedule 13G/A, by Sio Capital Management, LLC | 5.54% of the class | 5%+ stakes | Source |
| April 27, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.01% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Nantahala Capital Management, LLC | 7.52% of the class | 5%+ stakes | Source |
| February 5, 2026 | Stake report, Schedule 13G/A, by L1 Capital Pty Ltd | 13.6% of the class | 5%+ stakes | Source |
| January 29, 2026 | Stake report, Schedule 13D, by Medtronic plc | 16.2% of the class | 5%+ stakes | Source |
| January 21, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 4.9% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Anteris Technologies Global Corp. now and the warning signs.
Free to see. No signup.
Keep reading
More on Anteris Technologies Global Corp. and the records around it.
Anteris Technologies Global Corp. elsewhere on the record
- 5%+ stake filings Nov 2026
- IPO filing Nov 2025
- Form D filing Nov 2025
- Who owns it
Companies that share a holder
- Medtronic plc also filed stake reports on 2 other companies: Orchestra BioMed Holdings, Inc. (Feb 2026)
- L1 Capital Pty Ltd also filed stake reports on 4 other companies: Eldorado Gold Corp (May 2026)
- Sio Capital Management, LLC also filed stake reports on 9 other companies: Enveric Biosciences, Inc. (Nov 2026), Adagio Medical Holdings, Inc. (Jul 2026), PMV Pharmaceuticals, Inc. (Jul 2026)
Watch Anteris Technologies Global Corp.
Get an email when Anteris Technologies Global Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Anteris Technologies Global Corp.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Anteris Technologies Global Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Anteris Technologies Global Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 23 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-17 | Reported | not named in the filing | 8-K, 2026-09-17 | ||
| 2026-09-08 | In | Chief Financial Officer | 2026-09-11 | 8-K, 2026-09-08 | |
| 2026-05-13 | In | 8-K, 2026-05-13 | |||
| 2026-05-13 | In | 8-K, 2026-05-13 |
Who leads Anteris Technologies Global Corp., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Brent Moen, appointed, effective 2026-09-11 (filed 2026-09-08).
New leaders reset buying decisions — get the Full Report on Anteris Technologies Global Corp.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at Anteris Technologies Global Corp., with the record behind each one.
Find candidates like Chief Financial Officer at Anteris Technologies Global Corp.Every change, in the filing's words
Reported
If the holder's employment terminates due to death or permanent disability during the performance period, and provided that the minimum stock price hurdle has been met, any then-outstanding PSUs would vest as of the date of such termination, based on the volume weighted average price of the Company's Common Stock over the 60 trading days ending on the date of termination, and using linear interpolation between stock price hurdles.
- On September 12, 2026, the Company also approved award agreements under the Anteris Technologies Global Corp. Equity Incentive Plan (the "Equity Plan") for purposes effectuating the Contingent Option Grants (such agreements, the "Option Agreements").
- The Contingent Option Grants will be subject at all times to the terms of the applicable Option Agreement and the Equity Plan, including the clawback and forfeiture provisions thereof, and any other clawback or forfeiture policies adopted by the Company from time to time.
- The effectiveness of the Contingent Option Grants is contingent on and subject to stockholder approval.
- Pursuant to the Option Agreements, each Contingent Option Grant will generally vest and become exercisable in substantially equal installments on each of the first four anniversaries of the grant date, in each case subject to the holder remaining in the continuous employment of the Company or its subsidiaries.
- Pursuant to the Option Agreements, if the holder's employment terminates due to death or permanent disability during the vesting period, the holder's Contingent Option Grant will vest in full.
Appointed: Brent Moen, Chief Financial Officer, effective 2026-09-11
On September 4, 2026, Anteris Technologies Global Corp. (the "Company") appointed Brent Moen as its Chief Financial Officer, effective September 11, 2026.
- Mr. Moen, age 59, is an experienced financial executive with more than 25 years of leadership experience, including Chief Financial Officer roles at both public and private companies.
- He has extensive expertise in capital markets, investor relations, mergers and acquisitions, and scaling growth-oriented organizations, including medical technology companies.
- Mr. Moen previously served as Chief Financial Officer of LifeLens Technologies from September 2023 to March 2026, Chief Financial Officer of Tactile Systems Technology from September 2018 to April 2023, and Chief Financial Officer of Entellus Medical from May 2016 to March 2018.
- Mr. Moen holds a Bachelor of Accountancy from the University of North Dakota.
- With respect to the 2026 long-term incentive compensation award, the Committee approved the grant to Mr. Moen, effective September 11, 2026 (the "Date of Grant"), under the Anteris Technologies Global Corp. Equity Incentive Plan of nonqualified stock options with a target value of $500,000 and an exercise price equal to the fair market value of a share of the Company's common stock on the Date of Grant.
- This award will generally vest in substantially equal installments on each of the first three anniversaries of the Date of Grant and have a 10-year term.
Appointed: Susan Knight
Appointment of Ms. Susan Knight and Mr. Stephen Denaro to the Board of Directors On May 11, 2026 (May 12, 2026 in Australia), the Board of Directors (the "Board") of Anteris Technologies Global Corp. (the "Company") appointed Ms. Susan Knight and Mr. Stephen Denaro to serve on the Board.
Appointed: Stephen Denaro
Mr. Denaro will serve as a Class II Director, with a term expiring at the Company's 2026 annual meeting of stockholders.
- Ms. Knight will serve as a Class I Director, with a term expiring at the Company's 2028 annual meeting of stockholders and will serve on the Audit and Risk Committee of the Board.
- Ms. Knight most recently served as the Board Chair of Surmodics, Inc., a medical device provider, a position she held from 2015 until November 2025.
- She has served on corporate boards of directors since 2008 and has broad audit committee experience, including serving as committee chair at Surmodics, Inc., Greater Metropolitan Housing Corporation and Plato Learning.
- During her professional career, Ms. Knight was the Senior Vice President and Chief Financial Officer of MTS Systems Corporation from 2011 to 2014 and its Chief Financial Officer from 2001 to 2011.
- Prior to MTS Systems Corporation, Ms. Knight was the Vice President of Finance of the Home and Building Control Business of Honeywell, Inc. from 1994 to 2001.
- She also held various other management and executive financial positions during her 24-year career at Honeywell, Inc. Ms. Knight earned a BSBA in Accounting from Creighton University.
- Mr. Denaro rejoins the Board with deep knowledge of the Company and its strategic priorities.
- There are no understandings or arrangements between Ms. Knight and Mr. Denaro and any other person pursuant to which Ms. Knight or Mr. Denaro was selected to serve as a director of the Company.
Tools for this story
Each opens in a new tab, filled in for Anteris Technologies Global Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.